Inverse benefits due to drug marketing undermine patient safety and public health

Drugs that pharmaceutical companies market most aggressively to physicians and patients tend to offer less benefit and more harm to most patients — a phenomenon described as the "inverse benefit law" in a paper from the University of Texas Medical Branch at Galveston.

Read the whole article on Physorg

More from Physorg